BEDUA Trademark

Trademark Overview

On Wednesday, April 24, 2019, a trademark application was filed for BEDUA with the United States Patent and Trademark Office. The USPTO has given the BEDUA trademark a serial number of 88399554. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 27, 2023. This trademark is owned by Glaxo Group Limited. The BEDUA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
bedua

General Information

Serial Number88399554
Word MarkBEDUA
Filing DateWednesday, April 24, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 9, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, February 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 6, 2022SOU EXTENSION 5 GRANTED
Monday, June 27, 2022SOU EXTENSION 5 FILED
Monday, June 27, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 23, 2021SOU EXTENSION 4 GRANTED
Monday, December 13, 2021SOU EXTENSION 4 FILED
Thursday, December 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 13, 2021SOU TEAS EXTENSION RECEIVED
Friday, June 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 23, 2021SOU EXTENSION 3 GRANTED
Wednesday, June 23, 2021SOU EXTENSION 3 FILED
Wednesday, June 23, 2021SOU TEAS EXTENSION RECEIVED
Saturday, November 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 19, 2020SOU EXTENSION 2 GRANTED
Thursday, November 19, 2020SOU EXTENSION 2 FILED
Thursday, November 19, 2020SOU TEAS EXTENSION RECEIVED
Friday, March 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 4, 2020SOU EXTENSION 1 GRANTED
Wednesday, March 4, 2020SOU EXTENSION 1 FILED
Wednesday, March 4, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, January 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 21, 2019ASSIGNED TO LIE
Saturday, October 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 13, 2019NON-FINAL ACTION E-MAILED
Thursday, June 13, 2019NON-FINAL ACTION WRITTEN
Monday, June 10, 2019ASSIGNED TO EXAMINER
Thursday, May 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 27, 2019NEW APPLICATION ENTERED

Related Keywords

bedua pharmaceutical treatment preparations diseases disorders substances respiratory oncological genitourinary neurological